Combining Prostate‐Specific Antigen Density With PI‐RADS to Improve the Detection of Clinically Significant Prostate Cancer at MRI/TRUS Fusion‐Targeted Re‐Biopsy
The Prostate2025Vol. 86(5), pp. 582–591
Yuko Ono, Yuki Kohada, Shinsaku Tasaka, S Miyamoto, T. Hayashi, Yukiko Honda, Naoyuki Kitamura, Ryo Tasaka, Kohei Kobatake, Yohei Sekino, Hiroyuki Kitano, Keisuke Goto, Akihiro Goriki, Keisuke Hieda, Masao Kato, Yukio Takeshima, Nobuyuki Hinata
Abstract
Combining PSAD with PI-RADS improved risk stratification for csPCa in men who underwent MRI/TRUS fusion re-biopsies, while systematic biopsies added diagnostic value. These findings support individualized evidence-based re-biopsy strategies.